0001209191-22-058095.txt : 20221121
0001209191-22-058095.hdr.sgml : 20221121
20221121160814
ACCESSION NUMBER: 0001209191-22-058095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221117
FILED AS OF DATE: 20221121
DATE AS OF CHANGE: 20221121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Curley Joanne
CENTRAL INDEX KEY: 0001857670
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40407
FILM NUMBER: 221405822
MAIL ADDRESS:
STREET 1: C/O VISTAGEN THERAPEUTICS, INC.
STREET 2: 343 ALLERTON AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001831828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812744449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-770-0077
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-17
0
0001831828
Vera Therapeutics, Inc.
VERA
0001857670
Curley Joanne
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120
BRISBANE
CA
94005
0
1
0
0
Chief Development Officer
Class A Common Stock
2022-11-17
4
M
0
1078
6.3728
A
28393
D
Class A Common Stock
2022-11-17
4
S
0
1078
15.8606
D
27315
D
Class A Common Stock
2022-11-17
4
M
0
2211
2.8968
A
29526
D
Class A Common Stock
2022-11-17
4
S
0
2211
15.8436
D
27315
D
Stock Option (right to buy)
6.3728
2022-11-17
4
M
0
1078
0.00
D
2030-03-31
Class A Common Stock
1078
9717
D
Stock Option (right to buy)
2.8968
2022-11-17
4
M
0
2211
0.00
D
2030-12-15
Class A Common Stock
2211
38013
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.45 to $16.13, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.57 to $16.08, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter.
1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.
/s/ Joseph R. Young, Attorney-in-Fact
2022-11-21